MedDataX Logo

Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients

NCT ID: NCT01639417

Last Updated: 2016-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

39 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-05-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to better understand why some women with breast cancer develop chronic pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality

NCT01024114

Breast Cancer
WITHDRAWN

Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.

NCT05507034

Neoplasm, Breast Carcinoma Breast Chronic Pain
RECRUITING

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

NCT00043017

Breast Cancer
COMPLETED PHASE2

Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)

NCT01992432

Breast Cancer
ACTIVE_NOT_RECRUITING

Magnetic Resonance Imaging of Breast Cancer

NCT01035112

Breast Cancer Breast Cancer Non-invasive Breast Cancer
RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women with breast cancer who either have chronic pain or who do not have chronic pain will be asked to enroll. Those who participate will have pictures taken of their brain using MRI when they are lying still and also when pressure is being applied to their thumbnails. These pictures will be compared to patients without breast cancer who do not have pain and to those who have other types of pain, such as fibromyalgia. By taking and analyzing these pictures the investigators hope to understand more about why breast cancer survivors develop pain after their diagnosis and treatment. In the future the investigators hope to better treat the pain or possibly even prevent the pain from occurring in the first place.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Breast Cancer Survivor with and without chronic pain
* Able to undergo MRI
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lynn Henry

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lynn Henry

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lynn Henry, MD

Role: PRINCIPAL_INVESTIGATOR

University of Michigan Rogel Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan Comprehensive Cancer Center

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUM 55687

Identifier Type: OTHER

Identifier Source: secondary_id

UMCC 2011.115

Identifier Type: -

Identifier Source: org_study_id

NCT02180594

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MRI to Detect Breast Tumors in Women
NCT00003302 COMPLETED NA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
NCT00058058 COMPLETED NA
Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
NCT02125019 COMPLETED
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 UNKNOWN
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 COMPLETED
Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study
NCT01433640 COMPLETED
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802 COMPLETED
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
NCT03709186 COMPLETED
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
NCT00291304 TERMINATED PHASE2
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
NCT01938157 COMPLETED NA
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661 COMPLETED
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
NCT04877912 RECRUITING
Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy
NCT02679586 COMPLETED EARLY_PHASE1
Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx
NCT00802932 COMPLETED
Partial Breast Irradiation in a Low-risk Population Screened With MRI
NCT01255553 WITHDRAWN NA
Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation
NCT01684735 COMPLETED
Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer
NCT01259076 TERMINATED
Role of 3D Tomography in Breast Cancer
NCT01090687 COMPLETED
Histology of Functional Density in Premenopausal Breast
NCT01588834 COMPLETED
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
NCT05866458 RECRUITING
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT04030507 RECRUITING NA
Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
NCT03650803 COMPLETED NA
MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer
NCT00462696 COMPLETED NA
Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer
NCT00398437 UNKNOWN NA
Visualization Tool for Investigation of Breast Lesions
NCT00934297 TERMINATED